title: Mixed bag for industry as key drug act moves towards reauthorization.
authors.forename: Meredith
authors.initials: M
authors.lastname: Wadman
mesh_terms: D004345:Drug Industry; D007880:Legislation, Drug; D012308:Risk Management; D014481:United States; D014486:United States Food and Drug Administration